![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 37, 38577-38589, September 10, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the Department of Cell Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294-0005
Matrix metalloproteinases (MMPs) are a family of structurally related proteins with the collective capability to degrade all components of the extracellular matrix. Although MMP-mediated degradation of the extracellular matrix occurs physiologically, numerous pathological conditions exhibit increased MMP levels and excessive matrix degradation. Previous work from our laboratory has shown that interferon-
inhibits MMP-9 expression in a manner dependent upon STAT-1
. Here we extend our previous observations and show that the class II major histocompatibility complex transactivator (CIITA), a transcriptional target of STAT-1
, is also capable of inhibiting MMP-9 expression. By using stable cell lines that inducibly express CIITA or various mutant forms of CIITA, we show that CIITA requires the ability to bind the CREB-binding protein (CBP) to effectively inhibit MMP-9 expression. Furthermore, we show that CIITA-mediated inhibition of the MMP-9 gene does not rely on the transcriptional capability of CIITA. These findings support a model wherein CIITA inhibits MMP-9 expression by binding to and sequestering CBP, which reduces the levels of CBP at the MMP-9 promoter, inhibits levels of acetylated histone 3 at the MMP-9 promoter, and subsequently inhibits MMP-9 expression.
Received for publication, April 5, 2004 , and in revised form, July 6, 2004.
* This work was supported in part by United States Public Service NCI Grant CA-97247 and NINDS Grant NS-36765 from the National Institutes of Health (to E. N. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by National Institutes of Health Postdoctoral Fellowship T32 AI-07493.
To whom correspondence should be addressed: Office of the Chair, Dept. of Cell Biology, University of Alabama at Birmingham, 1530 3rd Ave. S., MCLM 395, Birmingham, AL 35294-0005. Tel.: 205-934-7667; Fax: 205-975-6748; E-mail: tika{at}uab.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Bartoszewski, A. Rab, G. Twitty, L. Stevenson, J. Fortenberry, A. Piotrowski, J. P. Dumanski, and Z. Bebok The Mechanism of Cystic Fibrosis Transmembrane Conductance Regulator Transcriptional Repression during the Unfolded Protein Response J. Biol. Chem., May 2, 2008; 283(18): 12154 - 12165. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, J. A. Harton, and B. D. Smith CIITA Mediates Interferon-{gamma} Repression of Collagen Transcription through Phosphorylation-dependent Interactions with Co-repressor Molecules J. Biol. Chem., January 18, 2008; 283(3): 1243 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Herrmann, R. S. Agrawal, S. F. Connolly, R. L. McCaffrey, J. Schlomann, and D. J. Kusner MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II J. Leukoc. Biol., September 1, 2007; 82(3): 686 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tosi, E. Pilotti, L. Mortara, A. D. L. Barbaro, C. Casoli, and R. S. Accolla Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y PNAS, August 22, 2006; 103(34): 12861 - 12866. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nozell, T. Laver, K. Patel, and E. N. Benveniste Mechanism of IFN-beta-Mediated Inhibition of IL-8 Gene Expression in Astroglioma Cells J. Immunol., July 15, 2006; 177(2): 822 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Sawa, D. Kamimura, G.-H. Jin, H. Morikawa, H. Kamon, M. Nishihara, K. Ishihara, M. Murakami, and T. Hirano Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells J. Exp. Med., June 12, 2006; 203(6): 1459 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Wang, S. Gregoire, E. Zika, L. Xiao, C. S. Li, H. Li, K. L. Wright, J. P. Ting, and X.-J. Yang Identification of the Ankyrin Repeat Proteins ANKRA and RFXANK as Novel Partners of Class IIa Histone Deacetylases J. Biol. Chem., August 12, 2005; 280(32): 29117 - 29127. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ma, M. J. Chang, R. C. Shah, and E. N. Benveniste Interferon-{gamma}-activated STAT-1{alpha} suppresses MMP-9 gene transcription by sequestration of the coactivators CBP/p300 J. Leukoc. Biol., August 1, 2005; 78(2): 515 - 523. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |